Skip to Main Content Menu Search Site

DoriVac: Boosting Antigen-specific Immune Responses with DNA Origami-Based Vaccines

Personalized cancer vaccine platform harnessing DNA nanotechnology to control the spacing and geometry of co-presented tumor antigen and adjuvant ligands with nano-scale precision

Want to learn more about DoriVac?

We are currently looking for funding opportunities, and collaborative partners in academia and industry.


Molecular Robotics

Technology Development Team
Key Features
  • Enhanced immunotherapies for cancer and infectious disease treatment
  • DNA nanostructures used for precise adjuvant and tumor antigen presentation
  • Precision medicine instrument to present patient and tumor-specific antigens
Close menu